TENX insider trading
NasdaqCM HealthcareTENAX THERAPEUTICS, INC.: insider trade history from SEC Form 4 filings.
About TENAX THERAPEUTICS, INC.
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.
Company website: www.tenaxthera.com
TENX insider activity at a glance
FilingIQ tracks 86 insider transactions for TENX in filings since Jan 20, 2015. The most recent transaction is dated Sep 16, 2026.
Across the full history, 62 open-market purchases
and 1 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TENX insider trades is 61.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest TENX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading TENX
Frequently asked
- How many insider trades does FilingIQ track for TENX?
- FilingIQ tracks 86 Form 4 insider transactions for TENX (TENAX THERAPEUTICS, INC.), covering filings from Jan 20, 2015 onwards. 13 of those are dated within the last 90 days.
- Are TENX insiders net buyers or net sellers?
- Across the full Form 4 history for TENX, 62 transactions (72%) were open-market purchases and 1 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TENX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is TENX in?
- TENAX THERAPEUTICS, INC. (TENX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $69.61M.
Methodology & sources
Every TENX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.